BAY-1112054

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBAY-1112054
Drug Alias NamePTEFb-BAY1BAY-1112054
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitorsPositive transcriptional elongation factor B inhibitors
TargetsCyclin-dependent kinase 9Positive transcriptional elongation factor B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLead Discovery CenterBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLead Discovery CenterBayer AG
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A